Cite
HARVARD Citation
Heldenbrand, S. et al. (2016). Multicenter evaluation of efficacy and safety of low‐dose versus high‐dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transplant infectious disease. 18 (6), pp. 904-912. [Online].